Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.97 USD | -0.38% | +8.73% | +1.14% |
May. 21 | CoStar Group has room for expansion | |
May. 16 | Transcript : Outlook Therapeutics, Inc., Q2 2024 Earnings Call, May 16, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.14% | 187M | |
+59.79% | 62.59B | |
-2.30% | 41.18B | |
+44.36% | 40.29B | |
-8.29% | 27.9B | |
+12.84% | 26.21B | |
-21.64% | 19.09B | |
+6.00% | 13.08B | |
+24.33% | 12.26B | |
+27.24% | 12.05B |
- Stock Market
- Equities
- OTLK Stock
- News Outlook Therapeutics, Inc.
- HC Wainwright Adjusts Price Target on Outlook Therapeutics to $5 From $6, Maintains Buy Rating